Vimarsana
Biggest News Aggregation in the World

Ventricular Rate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ventricular Rate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ventricular Rate Today - Breaking & Trending Today

2 'Strong Buy' Penny Stocks That Could Rally All the Way to $10 (or More) - Vimarsana News

2 'Strong Buy' Penny Stocks That Could Rally All the Way to $10 (or More)

Finding solid returns is the key to success in stock investing, but there are almost as many paths to that as there are investors. You can pack your portfolio with long-term stocks featuring slow appreciation; you can invest heavily in trending stocks that are riding a bubble, hoping to cash out at the right time; or you can buy into low-cost equities that feature high potential to boom. That last is the allure behind the penny stocks. Traditionally priced for a dollar or less per share, today t

Source: yahoo.com
Etripamil Nasal Spray Shows Promise in AFib with Rapid Ventricular Rates - Vimarsana News

Etripamil Nasal Spray Shows Promise in AFib with Rapid Ventricular Rates

An analysis of data from the NODE-303 trial provides insight into the effects of etripamil nasal spray in people with atrial fibrillation with rapid ventricular rates.

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

-  NDA submission for etripamil in patients with PSVT currently on track for 3Q23 -  Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on... | May 11, 2023

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...